Digital Life Sciences GmbH
Medical Technology · Gescher
Digital Life Sciences GmbH is a medical technology company based in Gescher, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Digital Life Sciences GmbH Address & Contact
Digital Life Sciences GmbH Overview
Digital Life Sciences GmbH is a digital company based in Gescher, North Rhine-Westphalia, that develops digital solutions for the life sciences and medical technology sectors. The company supports medical technology manufacturers in the digitalization of their products, processes, and market approval. With an interdisciplinary team of experts in software development, regulation, and medical technology, the company offers tailored solutions that consider both technical and legal requirements.
Services and Products
Digital Life Sciences offers software development for medical products, regulatory affairs consulting for Software as a Medical Device (SaMD), and Digital Health Applications (DiGA). With a clear focus on the specific needs of the industry, the company ensures that all products meet the latest regulatory requirements.
- Software Development: The company creates customized software solutions specifically tailored to the requirements of medical device manufacturers. These include both desktop applications and mobile applications for various end devices that provide an intuitive user experience.
- Regulatory Affairs Consulting: Digital Life Sciences is well-versed in the regulations of the Medical Device Regulation (MDR) 2017/745 as well as the FDA 21 CFR 820. This includes the preparation of technical documentation, conformity assessments, and assistance with the submission of required documents to the relevant authorities.
- Digital Health Applications (DiGA): In the context of digitalization in healthcare, the development of DiGA plays a central role. Digital Life Sciences supports companies in the planning, implementation, and evaluation of digital health applications that benefit patients and medical professionals.
Regulatory Classification
The regulatory classification of software as a medical device is a central challenge in medical technology. Digital Life Sciences specializes in guiding its clients through the complex approval process. The company relies on transparency and in-depth knowledge of the relevant legal frameworks to ensure that its clients' products meet the high standards of the MDR and the FDA. This also includes the preparation and conduct of clinical evaluations as well as support in post-market surveillance processes.
Location Gescher / North Rhine-Westphalia
Gescher is located in the western Münsterland in NRW, between Münster and Borken. The Westmünsterland is an industry-focused location for medium-sized businesses with a growing digital technology infrastructure and good accessibility to the Münster University ecosystem. These regions have a high density of companies in medical technology and adjacent sectors, enabling Digital Life Sciences to position itself in a dynamic environment.
Another advantage of the location is the close collaboration with research institutions and universities, which leads to innovative approaches in product development and adaptation. By integrating the latest research findings, it is ensured that Digital Life Sciences' solutions are always up to date and meet the current demands of the industry.
Regional Significance and Special Features
With its position in the prosperous Münsterland, Digital Life Sciences contributes to strengthening the digital health economy in North Rhine-Westphalia. The close collaboration with other companies and institutions in the region not only fosters innovation but also strengthens the competitiveness of the medical technology sector as a whole.
Furthermore, Digital Life Sciences is a pioneer in integrating young talents into medical technology. The company actively engages in training and develops programs to promote junior professionals in software and medical technology. This ensures that future innovations are based on a solid foundation of expertise and practical knowledge.
Other Medical Technology Companies: Medical Technology Overview | Medical Technology NRW | Laboratories
Frequently asked questions about Digital Life Sciences GmbH
What does Digital Life Sciences GmbH do?
Überblick über Digital Life Sciences GmbH Die Digital Life Sciences GmbH ist ein Unternehmen, das sich auf die Bereitstellung von digitalen Lösungen für die Life-Science-Branche s
Where is Digital Life Sciences GmbH located?
Digital Life Sciences GmbH is based in Gescher (Nordrhein-Westfalen). Detailed contact information, address and telephone number can be found on this page.
In which field does Digital Life Sciences GmbH operate?
Digital Life Sciences GmbH operates in the medical technology sector and offers specialised products and services for the German healthcare system.
Digital Life Sciences GmbH on social media
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.